Literature DB >> 10899282

Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel.

R DeBusk1, Y Drory, I Goldstein, G Jackson, S Kaul, S E Kimmel, J B Kostis, R A Kloner, M Lakin, C M Meston, M Mittleman, J E Muller, H Padma-Nathan, R C Rosen, R A Stein, R Zusman.   

Abstract

Sexual dysfunction is highly prevalent in both sexes and adversely affects patients' quality of life and well being. Given the frequent association between sexual dysfunction and cardiovascular disease, in addition to the potential cardiac risk of sexual activity itself, a consensus panel was convened to develop recommendations for clinical management of sexual dysfunction in patients with cardiovascular disease. Based upon a review of the research and presentations by invited experts, a classification system was developed for stratification of patients into high, low, and intermediate categories of cardiac risk. The large majority of patients are in the low-risk category, which includes patients with (1) controlled hypertension; (2) mild, stable angina; (3) successful coronary revascularization; (4) a history of uncomplicated myocardial infarction (MI); (5) mild valvular disease; and (6) no symptoms and <3 cardiovascular risk factors. These patients can be safely encouraged to initiate or resume sexual activity or to receive treatment for sexual dysfunction. An important exception is the use of sildenafil in patients taking nitrates in any form. Patients in the intermediate-risk category include those with (1) moderate angina; (2) a recent MI (<6 weeks); (3) left ventricular dysfunction and/or class II congestive heart failure; (4) nonsustained low-risk arrhythmias; and (5) >/=3 risk factors for coronary artery disease. These patients should receive further cardiologic evaluation before restratification into the low- or high-risk category. Finally, patients in the high-risk category include those with (1) unstable or refractory angina; (2) uncontrolled hypertension; (3) congestive heart failure (class III or IV); (4) very recent MI (<2 weeks); (5) high-risk arrhythmias; (6) obstructive cardiomyopathies; and (7) moderate-to-severe valvular disease. These patients should be stabilized by specific treatment for their cardiac condition before resuming sexual activity or being treated for sexual dysfunction. A simple algorithm is provided for guiding physicians in the management of sexual dysfunction in patients with varying degrees of cardiac risk.

Entities:  

Mesh:

Year:  2000        PMID: 10899282     DOI: 10.1016/s0002-9149(00)01117-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  The difference of heart rate recovery between males with and without erectile dysfunction.

Authors:  M Tolga Dogru; M Murad Basar; Ahmet Haciislamoglu
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-07       Impact factor: 1.468

Review 2.  Sexual activity and ischemic heart disease.

Authors:  Richard A Lange; Glenn N Levine
Journal:  Curr Cardiol Rep       Date:  2014-02       Impact factor: 2.931

Review 3.  Aetiology and management of male erectile dysfunction and female sexual dysfunction in patients with cardiovascular disease.

Authors:  Stephen L Archer; Ferrante S Gragasin; Linda Webster; Derek Bochinski; Evangelos D Michelakis
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  What is the best predictor of postoperative erectile function in patients who will undergo coronary artery bypass surgery?

Authors:  Fatih Hizli; Burak Işler; Zeki Güneş; M Ali Ozatik; Ferhat Berkmen
Journal:  Int Urol Nephrol       Date:  2007-03-02       Impact factor: 2.370

5.  Discussing sexual function in the cardiology practice.

Authors:  M P J Nicolai; S Both; S S Liem; R C M Pelger; H Putter; M J Schalij; H W Elzevier
Journal:  Clin Res Cardiol       Date:  2013-02-08       Impact factor: 5.460

Review 6.  Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction.

Authors:  Biljana Musicki; Anthony J Bella; Trinity J Bivalacqua; Kelvin P Davies; Michael E DiSanto; Nestor F Gonzalez-Cadavid; Johanna L Hannan; Noel N Kim; Carol A Podlasek; Christopher J Wingard; Arthur L Burnett
Journal:  J Sex Med       Date:  2015-12-08       Impact factor: 3.802

Review 7.  Safety and tolerability of oral erectile dysfunction treatments in the elderly.

Authors:  Andrea Salonia; Alberto Briganti; Piero Montorsi; Tommaso Maga; Federico Dehò; Giuseppe Zanni; Bruno Mazzoccoli; Nazareno Suardi; Patrizio Rigatti; Francesco Montorsi
Journal:  Drugs Aging       Date:  2005       Impact factor: 4.271

8.  Erectile dysfunction and hypertension: impact on cardiovascular risk and treatment.

Authors:  Valter Javaroni; Mario Fritsch Neves
Journal:  Int J Hypertens       Date:  2012-05-09       Impact factor: 2.420

9.  Attitudes and Performance of Cardiologists Toward Sexual Issues in Cardiovascular Patients.

Authors:  Razieh Salehian; Fatemeh Khodaeifar; Morteza Naserbakht; Azadeh Meybodi
Journal:  Sex Med       Date:  2016-12-14       Impact factor: 2.491

10.  Erectile dysfunction: A present day coronary disease risk equivalent.

Authors:  Rohit Kapoor; Aditya Kapoor
Journal:  Indian J Med Res       Date:  2016-09       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.